Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer

Metastatic Brain Cancer Clinical Trial

Official title:
A Phase 2, Multicenter, Exploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain Cancer

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the effect of the surgical intervention and insertion of GLIADEL wafers on the neurocognitive functioning in patients with metastatic brain cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00525590
Study type	Interventional
Source	Eisai Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	December 12, 2007
Completion date	December 1, 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05559853` - Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
Completed	`NCT00610285` - A Feasibility Study of Image Guided Noninvasive Single Fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases	N/A
Recruiting	`NCT01890278` - Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases	N/A
Recruiting	`NCT03721055` - Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor	N/A
Terminated	`NCT02213536` - Investigating the Efficacy of Hair Sparing Radiotherapy Treatment to the Whole Brain.
Active, not recruiting	`NCT01473485` - ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors	N/A